Search Results
You are looking at 1 - 8 of 8 items for
- Author: K. Ichikawa x
- Refine by access: All content x
Search for other papers by K. Ichikawa in
Google Scholar
PubMed
Search for other papers by J. Brtko in
Google Scholar
PubMed
Search for other papers by L. J. DeGroot in
Google Scholar
PubMed
Search for other papers by K. Hashizume in
Google Scholar
PubMed
Search for other papers by T. Yamada in
Google Scholar
PubMed
ABSTRACT
Rat liver nuclear thyroid hormone receptor lost 3,5,3′-tri-iodo-l-thyronine (T3)-binding activity with a half-life of 14 days, 4 h, 139 min, 62 min, 16 min or 6 min at 0, 36, 38, 40, 43 or 45 °C respectively, when present in crude nuclear extracts. Glycerol increased the half-life of the receptor during heat inactivation. Protection was reversible by removing the glycerol. The receptor was unstable at a pH below 6·0 or above 10·0. We also found a loss of the receptor activity during the separation of bound and free hormone using the resin test. Of several conditions tested for the separation of bound and free hormone, the addition of heated nuclear extract gave the most accurate estimation of bound hormone when using the resin test. Using these characteristics of the receptor, we purified the receptor to 1220 pmol T3-binding capacity/mg protein with a final yield of 14·6 μg/4 kg rat liver.
Journal of Endocrinology (1989) 120, 237–243
Search for other papers by A. Sakurai in
Google Scholar
PubMed
Search for other papers by K. Ichikawa in
Google Scholar
PubMed
Search for other papers by K. Hashizume in
Google Scholar
PubMed
Search for other papers by T. Miyamoto in
Google Scholar
PubMed
Search for other papers by K. Yamauchi in
Google Scholar
PubMed
Search for other papers by H. Ohtsuka in
Google Scholar
PubMed
Search for other papers by Y. Nishii in
Google Scholar
PubMed
Search for other papers by T. Yamada in
Google Scholar
PubMed
ABSTRACT
The effects of histone subfractions on rat liver thyroid hormone receptor–DNA interaction were examined using an in-vitro DNA-cellulose binding assay. H1 histones bound to DNA showed reversible and potent inhibition of receptor–DNA binding without affecting receptor–hormone binding. Poly-lysine, bovine serum albumin, ovalbumin and cytochrome c did not alter receptor–DNA binding. H1 histone subfractions (calf thymus lysine-rich histone (CTL)-1, CTL-2 and CTL-3) showed potent inhibition of receptor–DNA binding indistinguishable from each other. The quantity of H1 histone subfractions bound to DNA was the same. Although each subfraction has different functional properties, inhibition of receptor–DNA binding was a common feature of all the H1 histone subfractions, which is important for the non-random distribution of the receptor in chromatin.
Binding of the receptor to core histones was investigated; it was found to bind to core histones more potently than to other proteins (H1 histone, ovalbumin and cytochrome c). Among core histone subfractions, H4 histone bound to the receptor most potently and is the candidate to be one of the acceptor sites of the receptor in chromatin.
Journal of Endocrinology (1989) 121, 337–341
Search for other papers by K. Ichikawa in
Google Scholar
PubMed
Search for other papers by K. Hashizume in
Google Scholar
PubMed
Search for other papers by T. Miyamoto in
Google Scholar
PubMed
Search for other papers by Y. Nishii in
Google Scholar
PubMed
Search for other papers by K. Yamauchi in
Google Scholar
PubMed
Search for other papers by H. Ohtsuka in
Google Scholar
PubMed
Search for other papers by T. Yamada in
Google Scholar
PubMed
ABSTRACT
An aqueous two-phase partitioning study of partially purified nuclear thyroid hormone receptor from rat liver was performed. Stability of 3,5,3′-tri-iodo-l-thyronine (T3)–receptor complex and T3-binding activity in the presence of dextran or polyethylene glycol were assessed in order to determine the amount of occupied or unoccupied receptors in each phase. Partition coefficients were calculated as the ratio of receptor concentration in the upper polyethylene glycol-rich phase H2O and that in the lower dextranrich phase H2O. The partition coefficient was a sensitive function of the salt at pH above 6·1 and below 5·1. The salt had no effect on the partition coefficient at pH around 5·6. These results suggest that the isoelectric point of the thyroid hormone receptor is about 5·6, confirming previous determinations using isoelectric focusing. The partition coefficient of the receptor decreased upon T3 binding, regardless of the salt composition. In contrast, the partition coefficient of thyroxine-binding globulin increased upon T3 binding. Free T3 preferentially partitioned into the upper polyethylene glycol-rich phase and gave a partition coefficient higher than 1·0. These results strongly suggest that the decrease in the partition coefficient of the receptor upon hormone binding reflects conformational changes or changes in electrostatic properties of the receptor upon hormone binding. Such an alteration may be involved in biological activation of the receptor upon hormone binding.
J. Endocr. (1988) 119, 431–437
Search for other papers by T Nagasawa in
Google Scholar
PubMed
Search for other papers by K Ichikawa in
Google Scholar
PubMed
Search for other papers by K Minemura in
Google Scholar
PubMed
Search for other papers by M Hara in
Google Scholar
PubMed
Search for other papers by H Yajima in
Google Scholar
PubMed
Search for other papers by A Sakurai in
Google Scholar
PubMed
Search for other papers by H Kobayashi in
Google Scholar
PubMed
Search for other papers by K Hiramatsu in
Google Scholar
PubMed
Search for other papers by S Shigematsu in
Google Scholar
PubMed
Search for other papers by K Hashizume in
Google Scholar
PubMed
Abstract
Cellular and nuclear uptake of tri-iodothyronine (T3) and thyroxine (T4) was examined using the cultured cell line derived from rat liver, clone 9, and rat hepatoma, dRLH-84. The saturable cellular uptake of T3 and T4 was demonstrated in these cells. First we examined the cell cycle-dependent alteration of thyroid hormone uptake. Cellular T3 uptake was minimal in the early G1 phase and increased in the late G1 phase, reaching a maximal level in the S phase. Alterations in nuclear T3 uptake were in accordance with the changes in cellular T3 uptake. On the other hand, cellular and nuclear T4 uptake was unchanged throughout the cell cycle, suggesting the T3 specificity of the cell cycle-dependent alteration of cellular hormone transport. Next we examined the effect of sodium butyrate on the cellular transport of thyroid hormones. After treatment with 5 mm sodium butyrate, cellular and nuclear uptake of T3 was increased, reaching a maximal level (four- to sevenfold increase) after 48 h. When cells were incubated for 48 h with various concentrations of sodium butyrate, T3 uptake was enhanced by 1 mm sodium butyrate, reaching a maximal level with 5 mm. Although cellular T4 uptake was also increased after treatment with sodium butyrate, the degree and time-course of the increase were different from those of T3. The maximal increase in cellular T4 uptake (two- to threefold increase) was attained 20 h after treatment. Despite the increase in cellular T4 uptake, nuclear T4 uptake was decreased after treatment with sodium butyrate. For both T3 and T4, the enhanced cellular uptake was due to the increased Vmax without changes in the Michaelis–Menten constant. These data indicate that cellular transport of T4 is different from that of T3 in rat hepatic cells.
Journal of Endocrinology (1995) 147, 479–485
Search for other papers by Y. Nishii in
Google Scholar
PubMed
Search for other papers by K. Hashizume in
Google Scholar
PubMed
Search for other papers by K. Ichikawa in
Google Scholar
PubMed
Search for other papers by T. Miyamoto in
Google Scholar
PubMed
Search for other papers by S. Suzuki in
Google Scholar
PubMed
Search for other papers by T. Takeda in
Google Scholar
PubMed
Search for other papers by K. Yamauchi in
Google Scholar
PubMed
Search for other papers by M. Kobayashi in
Google Scholar
PubMed
Search for other papers by T. Yamada in
Google Scholar
PubMed
ABSTRACT
Changes in the amount of cytosolic 3,5,3′-tri-iodo-l-thyronine (T3)-binding protein (CTBP) and its activator during administration of l-thyroxine (T4) to thyroidectomized rats were investigated. Thyroidectomy decreased the amount of CTBP in the kidney, whereas the activator was not significantly modified by thyroidectomy. The activator was increased by administration of T4 to thyroidectomized rats. The amount of CTBP was also increased by administration of T4. The activator increased the maximal binding capacity (MBC) without changes in the affinity constant for T3 binding in CTBP. A T4-induced increase in MBC in cytosol inhibited nuclear T3 binding in vitro by competition of T3 binding between CTBP and the nuclear receptor.
These results suggest that thyroid hormone increases the capacity for cytosolic T3 binding through increasing the amount of CTBP and its activator, and that these increases play a role in regulating the amount of T3 that binds to its nuclear receptor.
Journal of Endocrinology (1989) 123, 99–104
Search for other papers by T Takeda in
Google Scholar
PubMed
Search for other papers by K Ichikawa in
Google Scholar
PubMed
Search for other papers by M Kobayashi in
Google Scholar
PubMed
Search for other papers by T Miyamoto in
Google Scholar
PubMed
Search for other papers by S Suzuki in
Google Scholar
PubMed
Search for other papers by Y Nishii in
Google Scholar
PubMed
Search for other papers by A Sakurai in
Google Scholar
PubMed
Search for other papers by T Nagasawa in
Google Scholar
PubMed
Search for other papers by M Katai in
Google Scholar
PubMed
Search for other papers by K Nakajima in
Google Scholar
PubMed
Search for other papers by K Hashizume in
Google Scholar
PubMed
Abstract
In order to study whether peripheral action of thyroid hormones is altered in insulin deficiency and to elucidate the biological consequences of alteration of the cytosolic 3,5,3′-tri-iodo-l-thyronine (T3) binding protein (CTBP), we measured malic enzyme, T3-responsive nuclear n protein, CTBP and nuclear thyroid hormone receptor in the liver and kidney of streptozotocin (STZ)-induced diabetic rats that were treated with or without insulin and/or a receptor-saturating dose of T3. The following results were obtained. 1. Induction of malic enzyme by T3 was apparently diminished in diabetic rats. However, supplementary injection of insulin enabled previously given T3 to take effect in diabetic rats. 2. T3-responsiveness of other hepatic proteins (n protein and CTBP) was not altered by insulin in diabetic rats. 3. The level of n protein was increased by insulin in diabetic rats in vivo and in perfused rat liver, indicating that the hepatic n protein is a novel insulin-responsive protein. T3 and insulin increased the level of n protein non-synergistically in diabetic rat liver. 4. Hepatic nuclear receptor levels were not altered in diabetic rats. 5. Hepatic CTBP levels were decreased in diabetic rats. This was not due to the toxic effect of STZ. Low CTBP level was only partially increased by insulin after 30 days of diabetic period. Renal CTBP levels were not altered in diabetic rats with or without insulin treatment. These results indicate that reduction of CTBP did not influence the hepatic response to a receptor-saturating dose of T3, although CTBP may regulate the nuclear T3 transport, and that fundamental action of a receptor-saturating dose of T3 was not attenuated in diabetic rat liver.
Journal of Endocrinology (1994) 143, 55–63
Search for other papers by K Ichikawa in
Google Scholar
PubMed
Search for other papers by T Miyamoto in
Google Scholar
PubMed
Search for other papers by T Kakizawa in
Google Scholar
PubMed
Search for other papers by S Suzuki in
Google Scholar
PubMed
Search for other papers by A Kaneko in
Google Scholar
PubMed
Search for other papers by J Mori in
Google Scholar
PubMed
Search for other papers by M Hara in
Google Scholar
PubMed
Search for other papers by M Kumagai in
Google Scholar
PubMed
Search for other papers by T Takeda in
Google Scholar
PubMed
Search for other papers by K Hashizume in
Google Scholar
PubMed
The thyromimetic compound SK&F L-94901 shows more potent thyromimetic activity in the liver than in the pituitary gland or heart when administered to rats. The mechanisms of liver-selectivity of SK&F L-94901 were examined using cultured rat hepatoma cells (dRLH-84) and rat pituitary tumor cells (GH3), both of which showed saturable cellular uptake of tri-iodothyronine (T(3)). When isolated nuclei with partial disruption of the outer nuclear membrane were used, SK L-94901 competed for [(125)I]T(3) binding to nuclear receptors almost equally in dRLH-84 and GH3 cells. SK L-94901 also did not discriminate thyroid hormone receptors (TR) alpha1 and beta1 in terms of binding affinity and activation of the thyroid hormone responsive element. In intact cells, however, SK L-94901 was a more potent inhibitor of nuclear [(125)I]T(3) binding in dRLH-84 cells than in GH3 cells at an early phase of the nuclear uptake process and after binding equilibrium. These data suggest that SK L-94901 is more effectively transported to nuclear TRs in hepatic cells than in pituitary cells and therefore shows liver-selective thyromimetic activity. In conclusion, SK L-94901 discriminates hepatic cells and pituitary cells at the nuclear transport process. The cellular transporters responsible for this discrimination were not evident.
Search for other papers by E Pap in
Google Scholar
PubMed
Search for other papers by K Racz in
Google Scholar
PubMed
Search for other papers by JK Kovacs in
Google Scholar
PubMed
Search for other papers by I Varga in
Google Scholar
PubMed
Search for other papers by E Buzas in
Google Scholar
PubMed
Search for other papers by B Madarasz in
Google Scholar
PubMed
Search for other papers by C Foldes in
Google Scholar
PubMed
Search for other papers by C Szalai in
Google Scholar
PubMed
Search for other papers by T Watanabe in
Google Scholar
PubMed
Search for other papers by H Ohtsu in
Google Scholar
PubMed
Search for other papers by A Ichikawa in
Google Scholar
PubMed
Search for other papers by A Nagy in
Google Scholar
PubMed
Search for other papers by A Falus in
Google Scholar
PubMed
Histamine is synthesized in cells by histidine decarboxylase (HDC). HDC-deficient knockout (KO) mice lack functional HDC and histamine in the tissues. In the present study we used this in vivo model for studying the role of HDC deficiency in the regulation of male steroid hormone metabolism. In agreement with earlier studies showing the lack of effects of central histamine on the basal secretion of gonadotrope hormones, we found no difference with in situ hybridization in the expression of GnRH in the hypothalamus of wild type and KO mice. The tissue concentrations of testosterone and several androgenic steroids were significantly elevated in the testes but not in the adrenal glands of HDC-KO mice. In contrast, serum estradiol levels failed to show a significant difference between the two groups. The weight of the testes was significantly smaller in both 7-day-old and adult KO mice. The ultrastructure of the adult testis indicated elevated steroid synthesis with more tightly coiled membranous whorls in Leydig cells. The present results suggest that changes in reproductive functions and sex steroid secretion in male HDC-KO mice are not due to altered hypothalamic GnRH expression but are probably related to definite modifications during fetal development of KO mice reinforced later by the lack of the effect of peripheral histamine. This may provide in vivo evidence that peripheral histamine is an important regulatory factor of male gonadal development during embryogenesis and of sex steroid metabolism later in adulthood.
